RxBenefits on the ULA Network
Top 10 Medications for Labor Funds to Monitor in 2026
Effectively managing your fund’s pharmacy benefits means staying ahead of the rapidly evolving healthcare landscape. For fund administrators, new specialty drugs and high-impact therapies coming to market presents both cost-saving opportunities and financial challenges.
New Therapies to Watch
Anticipating the pipeline of new treatments in 2026 and beyond is essential for protecting your fund’s bottom line. The upcoming year will introduce new therapies for complex conditions, ranging from next-generation weight loss and diabetes medications (GLP-1s) to novel treatments for inflammatory conditions and rare diseases.
Action Steps for Labor Funds
Specialty medications currently represent less than 2% of total prescriptions but often drive over half of total plan spend. That’s why navigating the new influx of drugs requires a proactive, clinical approach. Fund administrators should take decisive action by:
- Strengthening independent clinical management through prior authorization and step therapy.
- Implementing holistic support programs that pair specialized medications with lifestyle changes.
- Collaborating with your pharmacy benefits manager to negotiate pricing for new therapies and optimize your formularies.
Prepare your fund for the financial impact of tomorrow’s pharmacy landscape. Read the full article to explore the top medications to watch in 2026 and discover actionable steps to contain rising costs while delivering exceptional care to your members.
